Modernizing drug development and ensuring global equity in the organoid revolution
Abstract
Global regulatory shifts are accelerating the move from animal models to human-relevant systems like organoids and MPS. Without deliberate inclusion, Africa risks exclusion despite its high disease burden, limiting global health equity and full scientific potential.
Fields of Study & Subjects
Pharmaceutical Economics and Policy
Pharmaceutical Quality and Counterfeiting
Science
Research
and Medicine
Publication details
- Journal / source
- Communications Biology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 9
- Issue
- 1
- Publication date
- 17 April 2026
- Language
- EN